GlobeStar Therapeutics Corporation (GSTC)

Market Cap	1.24K -99.8%
Revenue (ttm)	n/a
Net Income	-919.30K
EPS	-0.00
Shares Out	1.24B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	779,619
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.0000 - 0.0003
Beta	1.39
RSI	64.68
Earnings Date	Jan 21, 2026

About GlobeStar Therapeutics

GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, engages in the provision of patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases in the United States. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. GlobeStar Therapeutics Corporation is based in New York, New York.

• Industry: Biotechnology
• Sector: Healthcare
• CEO: James Katzaroff
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: GSTC